ABPI

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

UK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamp

pharmaphorum caught up with Erik Nordkamp, outgoing president of the Association of the British Pharmaceutical Industry (ABPI), who

Share

X

UK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamp

https://pharmaphorum.com/views-analysis-market-access/uk-pharma-negotiating-choppy-seas-during-brexit-says-abpis-outgoing-president-nordkamp/

Pharma’s apprentice army is sculpting the future

A skills gap has been threatening to knock the shine off the UK biotechnology sector’s sparkling reputation for

Share

X

Pharma’s apprentice army is sculpting the future

https://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-apprentice-army-is-sculpting-the-future/

 

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

Overview Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK

Share

X

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

https://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/

New UK drug pricing deal promises faster medicines access

The UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the

Share

X

New UK drug pricing deal promises faster medicines access

https://pharmaphorum.com/news/new-uk-drug-pricing-deal-promises-faster-medicines-access/

Pharma body agrees five-year deal to boost NHS innovation

The UK’s pharma trade body, the Association of the British Pharmaceutical Industry (ABPI), has signed a five-year partnership

Share

X

Pharma body agrees five-year deal to boost NHS innovation

https://pharmaphorum.com/news/abpi-agrees-five-year-deal-to-boost-nhs-innovation/

Pharma braces for ‘hard Brexit’ despite new guidance

Trade body prepares for the worst-case scenario

Share

X

Pharma braces for ‘hard Brexit’ despite new guidance

https://pharmaphorum.com/news/pharma-braces-for-hard-brexit-despite-new-guidance/

UK reiterates post-Brexit EMA wishes – but reality gap remains

Analysis: while Theresa May has acknowledged difficult trade-offs for the first time, her Brexit demands remain an impossible

Share

X

UK reiterates post-Brexit EMA wishes – but reality gap remains

https://pharmaphorum.com/news/uk-reiterates-post-brexit-ema-wishes-reality-gap-remains/

Brexit: just one month to agree transition deal, says UK pharma

The UK pharma and biotech industries have warned that clarity on Brexit arrangements for medicines is needed urgently

Share

X

Brexit: just one month to agree transition deal, says UK pharma

https://pharmaphorum.com/news/brexit-just-one-month-agree-transition-deal-says-uk-pharma/

Despite progress, Brexit still threatens UK with relegation to second division

With time running out on Brexit, companies are already making long-term decisions.

Share

X

Despite progress, Brexit still threatens UK with relegation to second division

https://pharmaphorum.com/views-and-analysis/brexit-relegation-second-division/